GlassScriptPhysician profile
Steven R Cohen
NPI 1366775405
$3,626.56
in general payments reported to CMS, 2019-2025
15 companies · $1,315 in 2025
The $1,315 reported for 2025 was more than what 83% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $52.79 · 2021: $251 · 2022: $593 · 2023: $536 · 2024: $488 · 2025: $1,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,338.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $531.35 | 2021-2025 | Vabysmo, Susvimo |
| Regeneron Healthcare Solutions, INC. | $512.99 | 2019-2025 | Eylea, Eylea Hd |
| Apellis Pharmaceuticals, INC. | $402.99 | 2022-2025 | Syfovre |
| Novartis Pharmaceuticals Corporation | $399.32 | 2019-2021 | |
| Alimera Sciences, INC. | $394.08 | 2020-2024 | Iluvien, Yutiq |
| Ani Pharmaceuticals, INC. | $335.19 | 2024-2025 | Purified Cortrophin Gel, Iluvien, Yutiq |
| Abbvie INC. | $295.76 | 2022-2025 | Ozurdex |
| Biogen, INC. | $203.23 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $130.81 | 2025 | Acthar |
| Astellas Pharma US INC | $127.31 | 2023-2025 | Izervay |
| Regeneron Pharmaceuticals, INC. | $124.53 | 2022 | |
| Allergan, INC. | $58.11 | 2019-2021 | |
| Coherus Oncology, INC. | $49.75 | 2022-2023 | |
| Eyepoint US, INC. | $45.14 | 2021 | |
| Bausch & Lomb Americas INC. | $16.00 | 2025 | Xipere, Visudyne |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.